Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo Clinic [0.03%]
梅奥诊所关于医疗机构患者报告信息测量的协调与巩固的位置声明
David T Eton,Timothy J Beebe,Philip T Hagen et al.
David T Eton et al.
Patient-reported outcomes (PROs) capture how patients perceive their health and their health care; their use in clinical research is longstanding. Today, however, PROs increasingly are being used to inform the care of individual patients, a...
David Morley,Sarah Dummett,Laura Kelly et al.
David Morley et al.
Background: With an ageing population and increasing demands on health and social care services, there is growing importance attached to the management of long-term conditions, including maximizing the cost-effectiveness ...
Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases [0.03%]
延期释放的富马酸福必普利片长期临床疗效的真实世界研究：67例分析
Michael Prugger,Thomas Berger
Michael Prugger
Purpose: To assess the long-term effects of prolonged-release (PR) fampridine tablets (dalfampridine extended release) in clinical practice in patients with multiple sclerosis (MS) with walking impairment. ...
Optimal management of severe nausea and vomiting in migraine: improving patient outcomes [0.03%]
重度偏头痛性恶心和呕吐的优化管理：改善患者预后
Miguel Ja Láinez,Ana García-Casado,Francisco Gascón
Miguel Ja Láinez
Migraine is a common and potentially disabling disorder for patients, with wide-reaching implications for health care services, society, and the economy. Nausea and vomiting during migraine attacks are common symptoms that affect at least 6...
Translation and validation of the Western Ontario Osteoarthritis of the Shoulder (WOOS) index - the Danish version [0.03%]
西方多安关节炎肩部调查表(WOOS)的翻译和验证-丹麦版本
Jeppe V Rasmussen,John Jakobsen,Bo S Olsen et al.
Jeppe V Rasmussen et al.
Background and purpose: The Western Ontario Osteoarthritis of the Shoulder (WOOS) index is a patient-reported, disease-specific questionnaire for the measurement of the quality-of-life in patients with osteoarthritis. The...
Symptom burden and job absenteeism after treatment with additional catheter-directed thrombolysis for deep vein thrombosis [0.03%]
深静脉血栓形成后附加导管定向溶栓治疗的症状负担和旷工问题
Tone Enden,Nils-Einar Kløw,Per Morten Sandset
Tone Enden
Introduction: Additional catheter-directed thrombolysis (CDT) for acute deep vein thrombosis (DVT) reduces long-term postthrombotic syndrome and is likely to represent a cost-effective alternative treatment compared to th...
Karen Grimmer,Kate Beaton,Kevan Hendry
Karen Grimmer
Background: Functional decline (FD) in older people has commonly been measured in the hospital setting with instruments which have been validated on decrease over time in capacity to undertake basic activities of daily li...
Development and initial validation of a computer-administered health literacy assessment in Spanish and English: FLIGHT/VIDAS [0.03%]
西班牙语和英语计算机操作健康素养评估方法的初步开发与验证：FLIGHT/VIDAS
Raymond L Ownby,Amarilis Acevedo,Drenna Waldrop-Valverde et al.
Raymond L Ownby et al.
Current measures of health literacy have been criticized on a number of grounds, including use of a limited range of content, development on small and atypical patient groups, and poor psychometric characteristics. In this paper, we report ...
A systematic review of patient-reported measures of burden of treatment in three chronic diseases [0.03%]
三种慢性病的治疗负担的系统评价
David T Eton,Tarig A Elraiyah,Kathleen J Yost et al.
David T Eton et al.
Background: Burden of treatment refers to the workload of health care and its impact on patient functioning and well-being. There are a number of patient-reported measures that assess burden of treatment in single disease...
Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone [0.03%]
控制心房颤动对患者预后的影响：重点介绍达比加群酯的作用
C Anwar A Chahal,Omer Ali,Ross J Hunter et al.
C Anwar A Chahal et al.
Atrial fibrillation (AF) is a substantial cause of mortality and morbidity in the Western world. It is a massive burden on health care systems, and its prevalence is expected to double over the next 20 years. Trials evaluating antiarrhythmi...